Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeff Settleman

Showing results (21-30 of 65) with videos related to

Pageof 7
Sort By:
Nature Reviews. Drug Discovery|July 25, 2009
Factors underlying sensitivity of cancers to small-molecule kinase inhibitorsPasi A Jänne, Nathanael Gray, Jeff Settleman
Cancer Research|October 24, 2019
A Single-Step, High-Dose Selection Scheme Reveals Distinct Mechanisms of Acquired Resistance to Oncogenic Kinase Inhibition in Cancer CellsKenneth J Finn, Scott E Martin, Jeff Settleman
Future Oncology (London, England)|August 17, 2012
Mechanisms of acquired resistance to targeted cancer therapiesMark R Lackner, Timothy R Wilson, Jeff Settleman
Nature Reviews. Cancer|March 20, 2010
Cell line-based platforms to evaluate the therapeutic efficacy of candidate anticancer agentsSreenath V Sharma, Daniel A Haber, Jeff Settleman
Cancer Discovery|March 2, 2021
Thinking Differently about Cancer Treatment RegimensJeff Settleman, João M Fernandes Neto, René Bernards
Cancer Cell|August 16, 2011
Neuregulin-1-mediated autocrine signaling underlies sensitivity to HER2 kinase inhibitors in a subset of human cancersTimothy R Wilson, Diana Y Lee, Leanne Berry, et al.
Cancer Research|February 4, 2010
Acquired resistance of non-small cell lung cancer cells to MET kinase inhibition is mediated by a switch to epidermal growth factor receptor dependencyUltan McDermott, Raju V Pusapati, James G Christensen, et al.
Cancer Cell|March 10, 2021
A gene expression signature associated with ''K-Ras addiction'' reveals regulators of EMT and tumor cell survivalAnurag Singh, Patricia Greninger, Daniel Rhodes, et al.
Cancer Cell|July 29, 2014
Drug resistance via feedback activation of Stat3 in oncogene-addicted cancer cellsHo-June Lee, Guanglei Zhuang, Yi Cao, et al.
Scientific Reports|April 26, 2020
Unprovoked Stabilization and Nuclear Accumulation of the Naked Mole-Rat p53 ProteinMarian M Deuker, Kaitlyn N Lewis, Maria Ingaramo, et al.
Pageof 7

Showing results (21-30 of 65) with videos related to

Sort By:
Pageof 7
Nature Reviews. Drug Discovery|July 25, 2009
Factors underlying sensitivity of cancers to small-molecule kinase inhibitorsPasi A Jänne, Nathanael Gray, Jeff Settleman
Cancer Research|October 24, 2019
A Single-Step, High-Dose Selection Scheme Reveals Distinct Mechanisms of Acquired Resistance to Oncogenic Kinase Inhibition in Cancer CellsKenneth J Finn, Scott E Martin, Jeff Settleman
Future Oncology (London, England)|August 17, 2012
Mechanisms of acquired resistance to targeted cancer therapiesMark R Lackner, Timothy R Wilson, Jeff Settleman
Nature Reviews. Cancer|March 20, 2010
Cell line-based platforms to evaluate the therapeutic efficacy of candidate anticancer agentsSreenath V Sharma, Daniel A Haber, Jeff Settleman
Cancer Discovery|March 2, 2021
Thinking Differently about Cancer Treatment RegimensJeff Settleman, João M Fernandes Neto, René Bernards
Cancer Cell|August 16, 2011
Neuregulin-1-mediated autocrine signaling underlies sensitivity to HER2 kinase inhibitors in a subset of human cancersTimothy R Wilson, Diana Y Lee, Leanne Berry, et al.
Cancer Research|February 4, 2010
Acquired resistance of non-small cell lung cancer cells to MET kinase inhibition is mediated by a switch to epidermal growth factor receptor dependencyUltan McDermott, Raju V Pusapati, James G Christensen, et al.
Cancer Cell|March 10, 2021
A gene expression signature associated with ''K-Ras addiction'' reveals regulators of EMT and tumor cell survivalAnurag Singh, Patricia Greninger, Daniel Rhodes, et al.
Cancer Cell|July 29, 2014
Drug resistance via feedback activation of Stat3 in oncogene-addicted cancer cellsHo-June Lee, Guanglei Zhuang, Yi Cao, et al.
Scientific Reports|April 26, 2020
Unprovoked Stabilization and Nuclear Accumulation of the Naked Mole-Rat p53 ProteinMarian M Deuker, Kaitlyn N Lewis, Maria Ingaramo, et al.
Pageof 7